A phase III study to investigate a vaccine against COVID-19 (Q98681721)
Jump to navigation
Jump to search
No description defined
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III study to investigate a vaccine against COVID-19 |
No description defined |
Statements
A phase III randomized controlled trial to determine safety, efficacy, and immunogenicity of the non-replicating ChAdOx1 nCoV-19 vaccine (English)
0 references
1 May 2020
0 references
31 October 2021
0 references
11 June 2020
0 references
2,000
0 references